Chemotherapy-induced neutropenia and febrile neutropenia in the US: a beast of burden that needs to be tamed?
R Boccia, J Glaspy, J Crawford, M Aapro - The oncologist, 2022 - academic.oup.com
Neutropenia and febrile neutropenia (FN) are common complications of myelosuppressive
chemotherapy. This review provides an up-to-date assessment of the patient and cost …
chemotherapy. This review provides an up-to-date assessment of the patient and cost …
[HTML][HTML] Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of neoplastic supportive-care (CONS) …
Y Ba, Y Shi, W Jiang, J Feng, Y Cheng… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
Chemotherapy-induced neutropenia (CIN) is a potentially fatal and common complication in
myelosuppressive chemotherapy. The timing and grade of CIN may play prognostic and …
myelosuppressive chemotherapy. The timing and grade of CIN may play prognostic and …
Management of febrile neutropaenia: ESMO clinical practice guidelines
J Klastersky, J De Naurois, K Rolston… - Annals of …, 2016 - annalsofoncology.org
Despite major advances in prevention and treatment, FN remains one of the most frequent
and serious complications of cancer chemotherapy (ChT). It is a major cause of morbidity …
and serious complications of cancer chemotherapy (ChT). It is a major cause of morbidity …
Cancer chemotherapy: The case for therapeutic drug monitoring
CE Knezevic, W Clarke - Therapeutic drug monitoring, 2020 - journals.lww.com
The selection of an appropriate therapy and dosing regimen is a significant challenge in the
treatment of cancer. Although there are recommended standardized chemotherapy …
treatment of cancer. Although there are recommended standardized chemotherapy …
Application of the MASCC and CISNE risk-stratification scores to identify low-risk febrile neutropenic patients in the emergency department
CJ Coyne, V Le, JJ Brennan, EM Castillo… - Annals of emergency …, 2017 - Elsevier
Study objective Although validated risk-stratification tools have been used to send low-risk
febrile neutropenic patients home from clinic and inpatient settings, there is a dearth of …
febrile neutropenic patients home from clinic and inpatient settings, there is a dearth of …
Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting …
Abstract We compared the Multinational Association of Supportive Care in Cancer (MASCC)
and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for identifying serious …
and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for identifying serious …
Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism
PP Phiboonchaiyanan, C Kiratipaiboon… - Chemico-biological …, 2016 - Elsevier
Cancer stem cells (CSCs), a subpopulation of cancer cells with high aggressive behaviors,
have been identified in many types of cancer including lung cancer as one of the key …
have been identified in many types of cancer including lung cancer as one of the key …
[HTML][HTML] Beyond CAR T-cell therapy: continued monitoring and management of complications
V Reiser - Journal of the Advanced Practitioner in Oncology, 2020 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T-cell therapy has recently emerged as a groundbreaking
treatment for CD19-expressing hematologic malignancies and received rapid approval by …
treatment for CD19-expressing hematologic malignancies and received rapid approval by …
[HTML][HTML] Scoring Systems Identifying the Low-Risk Febril Neutropenia Patients in the Emergency Department: Usefulness of MASCC, CISNE and qSOFA
Objective: We aimed to investigate the effectiveness of quick Sequential Organ Failure
Assessment (qSOFA), Multinational Association for Supportive Care in Cancer (MASCC) …
Assessment (qSOFA), Multinational Association for Supportive Care in Cancer (MASCC) …
Bacterial infection among patients with multiple myeloma treated with bortezomib-based induction therapy: Real-world experience in an asian cancer center
Background The treatment landscape for multiple myeloma (MM) has progressed
significantly, and over the past decade, bortezomib-based induction therapy has been a …
significantly, and over the past decade, bortezomib-based induction therapy has been a …